Detalles de la búsqueda
1.
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet
; 403(10431): 1061-1070, 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402886
2.
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Mol Cancer
; 23(1): 61, 2024 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519913
3.
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
Br J Cancer
; 130(3): 417-424, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097741
4.
Late phase 1 studies: concepts and outcomes.
Lancet Oncol
; 22(10): e446-e455, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34592194
5.
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Lancet Oncol
; 21(9): 1147-1154, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717180
6.
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors.
Oncoimmunology
; 12(1): 2150472, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36545254
7.
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.
Cancer Discov
; 13(4): 858-879, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669143
8.
PD-1 iNhibitor and chemotherapy with concurrent IRradiation at VAried tumor sites in advanced Non-small cell lung cAncer: the Prospective Randomized Phase 3 NIRVANA-Lung Trial.
Clin Lung Cancer
; 23(3): e252-e256, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34810130
9.
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial.
Lung Cancer
; 166: 255-264, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953624
10.
Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias.
Cancer Treat Rev
; 110: 102452, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35998515
11.
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Eur Urol
; 82(2): 172-179, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35599187
12.
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.
J Exp Clin Cancer Res
; 41(1): 217, 2022 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794623
13.
Intratumoral Immunotherapy: From Trial Design to Clinical Practice.
Clin Cancer Res
; 27(3): 665-679, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32943460
14.
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy.
Clin Cancer Res
; 27(2): 492-503, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887723
15.
Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non-Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy.
JCO Precis Oncol
; 4: 829-840, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050757
16.
Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2).
Clin Lung Cancer
; 20(3): 222-230, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30679079
17.
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology.
Comput Math Methods Med
; 2018: 1672176, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29568321
18.
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
JAMA Oncol
; 4(11): 1543-1552, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30193240
19.
A Novel Spectroscopically Determined Pharmacodynamic Biomarker for Skin Toxicity in Cancer Patients Treated with Targeted Agents.
Cancer Res
; 77(2): 557-565, 2017 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27836854
20.
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.
JAMA Dermatol
; 152(1): 45-51, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26501224